Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Cablivi 10 mg powder and solvent for solution for injection

Active Ingredient:
caplacizumab
Company:  
SANOFI See contact details
ATC code: 
B01AX07
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Cablivi 10 mg powder and solvent for solution for injection – Patient Card - Risk Minimisation Information for Patients

This Patient Alert Card has been developed for prescribers and healthcare professionals (HCPs) involved in the care of patients treated with Cablivi (caplacizumab), to provide further information about the potential serious risks associated with the use of this medicine. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

SANOFI
Company image
Address
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0)800 035 2525
Telephone
+44 (0)118 354 3000